What is the treatment for Spontaneous Coronary Artery Dissection (SCAD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Spontaneous Coronary Artery Dissection (SCAD)

Conservative management is the first-line treatment for clinically stable SCAD patients, while revascularization should be reserved only for cases with ongoing ischemia, hemodynamic instability, or left main/proximal two-vessel involvement with critical flow limitation. 1, 2

Initial Management Approach

  • Treatment strategy depends on clinical presentation, hemodynamic status, and coronary anatomy 1
  • For clinically stable patients without high-risk features:
    • Conservative medical therapy is recommended 1, 2
    • Inpatient monitoring for 3-5 days to observe for early complications 1, 2
  • Revascularization (PCI or CABG) should be considered only in:
    • Patients with actively ongoing ischemia 1
    • Hemodynamic instability 1
    • Left main or proximal two-vessel coronary dissection with critical flow limitation 1, 2

Medical Therapy

  • Beta-blockers:
    • Strongly recommended as they have been associated with reduced risk of recurrent SCAD 2, 3
    • Should be continued long-term for prevention of recurrence 2, 4
  • Antiplatelet therapy:
    • Single antiplatelet therapy (SAPT) with aspirin is appropriate for conservatively managed patients without high-risk angiographic features 3, 5
    • Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel should be used if PCI was performed, continuing for 12 months 3, 4
    • Potent P2Y12 inhibitors (ticagrelor, prasugrel) should be avoided in SCAD patients 3
    • Recent evidence suggests SAPT may be associated with better outcomes than DAPT in conservatively managed patients (6% vs 18.9% MACE rate) 5
  • Blood pressure management:
    • Aggressive anti-hypertensive therapy is recommended as hypertension is an independent predictor of recurrent SCAD 2

Medications to Avoid

  • Fibrinolytic agents and anticoagulants should be avoided as they could worsen the intramural hematoma 3, 4
  • Glycoprotein IIb/IIIa inhibitors are contraindicated 4
  • Potent P2Y12 inhibitors (ticagrelor, prasugrel) should be avoided when possible 3

Revascularization Considerations

  • PCI in SCAD has high failure rates (approximately 50%) and may worsen the dissection 1
  • If revascularization is necessary:
    • PCI for focal, accessible lesions with ongoing ischemia 1
    • CABG for left main or multivessel involvement, especially when PCI is technically challenging 1, 2
  • Intravascular imaging (OCT/IVUS) should only be used if revascularization decision has already been made, as it may trigger vessel closure 1

Long-term Management and Follow-up

  • Long-term beta-blocker therapy should be continued to prevent recurrence 2, 3
  • For patients with preserved left ventricular function, the optimal duration of beta-blocker therapy is being investigated in ongoing trials 6
  • Consider coronary CT angiography for follow-up in patients with persistent or recurrent symptoms 2
  • Evaluate for associated conditions, particularly fibromuscular dysplasia which occurs in up to 72% of SCAD cases 7

Management of Post-SCAD Chest Pain

  • New acute ACS: Urgent evaluation following acute chest pain guidelines 1
  • New or persistent stable angina: Evaluate with stress imaging (echo, CMR, nuclear perfusion) 1
  • Atypical symptoms: Consider non-cardiac causes, address symptom triggers, and evaluate for coronary vasospasm or endothelial dysfunction 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Spontaneous Coronary Artery Dissection (SCAD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drugs for spontaneous coronary dissection: a few untrusted options.

Frontiers in cardiovascular medicine, 2023

Guideline

Migraine Treatment in Spontaneous Coronary Artery Dissection (SCAD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.